Sels et Dérivés d’API
Les sels des Ingrédients Pharmaceutiques Actifs (API) sont des composés formés par la réaction d’un acide avec une base, aboutissant à un équilibre ionique. Ces sels améliorent souvent la solubilité et la stabilité des API, facilitant ainsi leur absorption par l’organisme. Les dérivés des API sont des variantes chimiques d’un principe actif qui peuvent présenter des propriétés améliorées ou modifiées afin d’optimiser leur efficacité thérapeutique. Les sels d’API sont utilisés dans la formulation de médicaments oraux, injectables et topiques. De plus, les dérivés d’API peuvent améliorer la pharmacocinétique des médicaments, notamment en permettant une libération contrôlée des substances actives.
Chez CymitQuimica, nous proposons des sels et dérivés d’API avec la pureté et la qualité requises pour la recherche et le développement de formulations pharmaceutiques.
79450 produits trouvés pour "Sels et Dérivés d’API"
Trier par
Degré de pureté (%)
0
100
|
0
|
50
|
90
|
95
|
100
Alosetron Related Compound A (5-Methyl-2,3,4,5-tetrahydro-1H-pyrido[4,3-b]indol-1-one)
CAS :Lactams not elsewhere specified or includedFormule :C12H12N2OCouleur et forme :Off-White Brown PowderMasse moléculaire :200.09496Ticagrelor Related Compound A ((1R,2S)-2-(3,4-difluorophenyl)cyclopropan-1-amine (R)-mandelate)
CAS :Aromatic monoamines not elsewhere specified or included and their derivatives, salts therofFormule :C9H9F2N·C8H8O3Couleur et forme :White Yellow SolidMasse moléculaire :321.11765Phenobarbital Related Compound B (5-Ethyl-6-imino-5-phenyldihydropyrimidine-2,4(1H,3H)-dione)
CAS :Compounds containing a pyrimidine ring (whether or not hydrogenated) or piperazine ring in the structure, nesoiFormule :C12H13N3O2Couleur et forme :Off-White SolidMasse moléculaire :231.10078p-Toluidine
CAS :Toluidines (aminotoluenes) and their derivatives, salts thereofFormule :C7H9NCouleur et forme :Off-White Brown Crystalline PowderMasse moléculaire :107.0735Clopidogrel Diester Analog (R)-1-(2-chlorophenyl)-2-methoxy-2-oxoethyl (S)-2-(2-chlorophenyl)-2-(6,7-dihydrothieno[3,2-c]pyridin-5(4H)-yl)acetate, sulfate
CAS :Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormule :C24H21Cl2NO4S·H2SO4Couleur et forme :White Off-White SolidMasse moléculaire :587.02421Desthiophenerivaroxaban Methylcarbamate Analog (methyl ((2-oxo-3-(4-(3-oxomorpholino)phenyl)oxazolidin-5-yl)methyl)carbamate)
CAS :Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormule :C16H19N3O6Couleur et forme :White Off-White SolidMasse moléculaire :349.12739Tetrabenazine Related Compound C ((3RS,11bRS)-3-Butyl-9,10-dimethoxy-1,3,4,6,7,11b-hexahydro-2H-pyrido[2,1-a]isoquinolin-2-one)
CAS :Aromatic or modified aromatic heterocyclic compounds withnitrogen hetero-atom(s) only nesoiFormule :C19H27NO3Couleur et forme :Off-White PowderMasse moléculaire :317.19909Succinylmonocholine Chloride
CAS :Quaternary ammonium salts and hydroxides, whether or not chemically defined, nesoiFormule :C9H18ClNO4Couleur et forme :White PowderMasse moléculaire :239.09244Testosterone Enanthate Related Compound G (Androst-4,9(11)-dien-3-one-17β-yl heptanoate)
CAS :Adrenal cortical hormones and their derivatives nesoiFormule :C26H38O3Couleur et forme :White Waxy SolidMasse moléculaire :398.59Temazepam Related Compound G (7-Chloro-1,4-dimethyl-5-phenyl-4,5-dihydro-1H-1,4-benzodiazepine-2,3-dione)
CAS :Heterocyclic compounds (excluding aromatic or modifiedFormule :C17H15ClN2O2Couleur et forme :PowderMasse moléculaire :314.77Spironolactone Related Compound B ((2'R)-7α-(Acetylthio)-5'H-spiro[androst-4-ene-17,2'-furan]-3,5'-dione)
CAS :Lactones, nesoiFormule :C24H30O4SCouleur et forme :Off-White SolidMasse moléculaire :414.18648Dichlorothienoic Acid (4,5-dichlorothiophene-2-carboxylic acid)
CAS :Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormule :C5H2Cl2O2SCouleur et forme :Off-White SolidMasse moléculaire :195.91526Estradiol Related Compound C (1,3,5(10)-estratrien-3,17β-diol-6-one)
CAS :Estrogens and progestinsFormule :C18H22O3Couleur et forme :White Yellow Crystalline PowderMasse moléculaire :286.37Phenoxybenzamine Nitrile (3-[Benzyl(1-phenoxypropan-2-yl)amino]propanenitrile)
Nitrile function compounds, not elsewhere specified or includedFormule :C19H22N2OCouleur et forme :Yellow Viscous LiquidMasse moléculaire :294.4 g/molFosinopril Related Compound B ((4S)-4-Cyclohexyl-1-[(R)-[(S)-1-hydroxy-2-methylpropoxy](4-phenylbutyl)phosphinyl]acetyl-D-proline propionate (ester), hemibarium salt, sesquihydrate)
CAS :Heterocyclic compounds with nitrogen hetero-atom(s) only, aromatic or modified aromatic, nesoiFormule :C30H45NO7PBaH2OCouleur et forme :White PowderMasse moléculaire :562.29336Fluorouracil Related Compound A (Pyrimidine-2,4,6(1H,3H,5H)-trione)
CAS :Malonylurea (barbituric acid) and its saltsFormule :C4H4N2O3Couleur et forme :White PowderMasse moléculaire :128.1Ketorolac Related Compound C (5-benzoyl-2,3-dihydro-1H-pyrrolizin-1-one)
CAS :Aromatic or modified aromatic heterocyclic compounds withnitrogen hetero-atom(s) only nesoiFormule :C14H11NO2Couleur et forme :Yellow SolidMasse moléculaire :225.07898Anastrozole Related Compound A (2,2'-(5-methyl-1,3-phenylene)bis(2-methylpropanenitrile))
CAS :Nitrile function compounds, not elsewhere specified orFormule :C15H18N2Couleur et forme :Yellow PowderMasse moléculaire :226.147Theophylline Related Compound F (7-(2-Hydroxyethyl)-1,3-dimethyl-3,7-dihydro-1H-purine-2,6-dione)
CAS :Theophylline and aminophylline (excluding fenetylline) and their derivatives, salts thereof, not elsewhere specified or includedFormule :C9H12N4O3Couleur et forme :White PowderMasse moléculaire :224.22Levalbuterol Related Compound A (4-(2-tert-Butylamino-ethyl)-2-hydroxymethyl-phenol)
CAS :Aromatic amino-alcohol-phenols, aromatic amino-acid-phenols and other aromatic amino compounds with oxygen functionFormule :C13H21NO2Couleur et forme :Off-White PowderMasse moléculaire :223.31Rabeprazole Related Compound B (2-{[(1H-benzo[d]imidazol-2-yl)sulfinyl]methyl}-4-(3-methoxypropoxy)-3-methylpyridine 1-oxide)
CAS :Aromatic or modified aromatic drugs with nitrogen hetero-atom(s) only, not elsewhere specified or includedFormule :C18H21N3O4SCouleur et forme :White PowderMasse moléculaire :375.44Dopamine Related Compound B (4-(2-Aminoethyl)-2-methoxyphenol hydrochloride)
CAS :Amino-naphthols and other amino-phenols, their ethers and esters, other than those cont more than one kind of oxygen function; salts thereof nesoiFormule :C9H13NO2·HClCouleur et forme :Off-White SolidMasse moléculaire :203.07131Memantine Related Compound A (1,3-Dimethyladamantane)
CAS :Cyclanes, cyclenes and cycloterpenes, excluding cyclohexaneFormule :C12H20Couleur et forme :Clear Colorless LiquidMasse moléculaire :164.1565Proguanil Related Compound G (1-(3-chlorophenyl)-5-isopropylbiguanide hydrochloride)
CAS :Aromatic imines and their derivatives, salts thereofFormule :C11H16ClN5·HClCouleur et forme :White Crystalline PowderMasse moléculaire :290.19Artemether Related Compound B ((3R,5aS,6R,8aS,9R,10R,12R,12aR)-Decahydro-10-methoxy-3,6,9-trimethyl-3,12-epoxy-12H-pyrano[4,3-j]-1,2-benzodioxepin)
CAS :Heterocyclic compounds with oxygen hetero-atom(s) onlyFormule :C16H26O5Couleur et forme :White Solid PowderMasse moléculaire :298.17802Mesna Related Compound A (2-(Acetylthio)ethane-1-sulfonic acid, potassium salt, crystal adduct with potassium chloride)
Organo-sulfur compounds, nesoiFormule :C4H7KO4S2·KClCouleur et forme :White PowderMasse moléculaire :221.94228Antazoline Related Compound A (N-(2-Aminoethyl)-2-[benzyl(phenyl)amino]acetamide)
CAS :Aromatic cyclic amides (including cyclic carbamates) and their derivatives; salts thereofFormule :C17H21N3OCouleur et forme :SolidMasse moléculaire :283.37Perindopril Related Compound E ((2S,3aS,7aS)-1-{(S)-2-[(S)-1-Isopropoxy-1-oxopentan-2-ylamino]propanoyl}octahydro-1H-indole-2-carboxylic acid, tert-butylamine)
Heterocyclic compounds with nitrogen hetero-atom(s) only, excluding aromatic or modified aromaticFormule :C20H34N2O5·C4H11NCouleur et forme :White PowderMasse moléculaire :382.2467715-Keto-travoprost (isopropyl (Z)-7-((1R,2R,3R,5S)-3,5-dihydroxy-2-((E)-3-oxo-4-(3-(trifluoromethyl)phenoxy)but-1-en-1-yl)cyclopentyl)hept-5-enoate)
CAS :Carboxylic acids with additional oxygen function and their anhydrides, halides, peroxides etc, nesoiFormule :C26H33F3O6Couleur et forme :Pale Yellow LiquidMasse moléculaire :498.22292Flurazepam Related Compound F (7-chloro-5-(2-fluorophenyl)-1,3-dihydro-2H-1,4-benzodiazepin-2-one)
CAS :Aromatic or modified aromatic heterocyclic compounds withnitrogen hetero-atom(s) only nesoiFormule :C15H10ClFN2OCouleur et forme :White PowderMasse moléculaire :288.04657Ticagrelor R,S-Cyclopropyl Isomer
CAS :Compounds containing a pyrimidine ring (whether or not hydrogenated) or piperazine ring in the structure, nesoiFormule :C23H28F2N6O4SCouleur et forme :White Off-White SolidMasse moléculaire :522.18608Prochlorperazine Related Compound A (4-Chloro-10-[3-(4-methylpiperazin-1-yl)propyl]-10H-phenothiazine dihydrochloride)
CAS :Compounds (excluding drugs) containing a phenothiazine ring-system (whether or not hydrogenated), not further fusedFormule :C20H24ClN3S·2HClCouleur et forme :Light Grey PowderMasse moléculaire :446.86Allopurinol Related Compound F (ethyl-(E/Z)-3-(2-carbethoxy-2-cyanoethenyl)amino-1H-pyrazole-4-carboxylate)
CAS :Compounds containing an unfused pyrazole ring, whether or not hydrogenated, in the structure, nesoiFormule :C12H14N4O4Couleur et forme :PowderMasse moléculaire :278.1Clarithromycin Impurity D (N-desmethyl clarithromycin)
CAS :Lactones nesoiFormule :C37H67NO13Couleur et forme :White Off-White PowderMasse moléculaire :733.46124Dermatan Sulfate
CAS :Natural polymers & modified natural polymers, in primary forms, nesoiCouleur et forme :White PowderMasse moléculaire :Average 46275Articaine Related Compound B (4-methyl-3-{[2-(propylamino)propanoyl]amino}thiophene-2-carboxylic acid)
CAS :Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormule :C12H18N2O3SCouleur et forme :PowderMasse moléculaire :270.35Eplerenone Related Compound L ( 9,11α-Epoxy-6β-hydroxy-7α-(methoxycarbonyl)-3-oxo-17α-pregn-4-ene-21,17-carbolactone)
CAS :Lactones, nesoiFormule :C24H30O7Couleur et forme :White SolidMasse moléculaire :430.19915Bendamustine Related Compound D (4-{5-[(2-Chloroethyl)amino]-1-methyl-1H -benzimidazol-2-yl}butanoic acid hydrochloride)
CAS :Heterocyclic compounds with nitrogen hetero-atom(s) only, aromatic or modified aromatic, nesoiFormule :C14H18ClN3O2HClCouleur et forme :Pink SolidMasse moléculaire :332.23Efavirenz Racemic ((+/-)-6-chloro-4-(cyclopropylethynyl)-1,4-dihydro-4-(trifluoromethyl)-2H-3,1-benzoxazin-2-one)
CAS :Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormule :C14H9ClF3NO2Couleur et forme :White PowderMasse moléculaire :315.02739Ritonavir Related Compounds Mixture
CAS :Diagnostic or lab reagents on a backing, prepared diagnostic or lab reagents whether or not on a backing, whether or not in the form of kits, nesoiCouleur et forme :White Light Yellow PowderEplerenone Related Compound F ( Sodium 9,11α-Epoxy-17-hydroxy-7α-(methoxycarbonyl)-3-oxo-17α-pregn-4-ene-21-carboxylate)
CAS :Carboxylic acids with additional oxygen function and their anhydrides, halides, peroxides etc, nesoiFormule :C24H31NaO7Couleur et forme :Light Yellow SolidMasse moléculaire :454.19675Trisalicylic Acid
CAS :Esters of salicylic acid and its salts not elsewhere specified or includedFormule :C21H14O7Couleur et forme :White PowderMasse moléculaire :378.34Tetrahydrozoline Related Compound A (1,2,3,4-Tetrahydronaphthalene-1-carbonitrile)
CAS :Nitrile function compounds, nesoiFormule :C11H11NCouleur et forme :Colorless Light Yellow Yellow Green LiquidMasse moléculaire :157.08915Deferasirox System Suitability Mixture (A mixture containing Deferasirox, Benzoxazinone analog, Deferasirox ethyl ester, Deferasirox 1,2-isomer, Deferasirox 1,3-isomer and Salicylimide)
Aromatic or modified aromatic heterocyclic compounds withnitrogen heteroCouleur et forme :White PowderMemantine Related Compound B (3,5-Dimethyladamantane-1-ol)
CAS :Other cyclanic, cyclenic or cycloterpenic alcohols and their halogenated, sulfonated, nitrated or nitrosated derivativesFormule :C12H20OCouleur et forme :Off-White Crystalline PowderMasse moléculaire :180.15142Lansoprazole Related Compound B (2-[[[3-Methyl-4-(2,2,2-trifluoroethoxy)-pyridin-2-yl]methyl]sulfanyl]-1H-benzimidazole monohydrate)
CAS :Compounds containing an unfused pyridine ring in the structure, nesoiFormule :C16H14F3N3OS·H2OCouleur et forme :Brown Crystalline PowderMasse moléculaire :371.38Zidovudine Related Compound C (thymine)
CAS :Compounds containing a pyrimidine ring (whether or notFormule :C5H6N2O2Couleur et forme :PowderMasse moléculaire :126.04293Sulfamethoxazole Related Compound F (4-amino-N-(3-methylisoxazol-5-yl)benzenesulfonamide)
CAS :Sulfonamides, nesoiFormule :C10H11N3O3SCouleur et forme :Off-White Yellow Fine PowderMasse moléculaire :253.05211Rivaroxaban Related Compound B ((S)-N-({2-Oxo-3-[4-(3-oxomorpholino)phenyl]oxazolidin-5-yl}methyl)acetamide)
CAS :Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormule :C16H19N3O5Couleur et forme :White Off-White SolidMasse moléculaire :333.34Lorazepam Related Compound D (6-Chloro-4-(o-chlorophenyl)-2-quinazolinecarboxylic Acid)
CAS :Aromatic or modified aromatic drugs with nitrogen heterFormule :C15H8Cl2N2O2Couleur et forme :White PowderMasse moléculaire :317.99628Primidone Related Compound C (2-phenyl butyramide)
CAS :Aromatic cyclic amides (including cyclic carbamates) anFormule :C10H13NOCouleur et forme :White Crystalline PowderMasse moléculaire :163.09971Azelastine Related Compound E (3-(4-chlorobenzylidene)isobenzofuran-1(3H)-one)
Lactones nesoiFormule :C15H9ClO2Couleur et forme :PowderMasse moléculaire :256.68Rivaroxaban isomer (4-(4-(((2-(5-chlorothiophen-2-yl)-4,5-dihydrooxazol-5-yl)methyl)amino)phenyl)morpholin-3-one)
CAS :Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormule :C18H18ClN3O3SCouleur et forme :White Off-White SolidMasse moléculaire :391.07574Abacavir Related Compound B ([4-(2,5-diamino-6-chloropyrimidin-4-ylamino)cyclopent-2-enyl]methanol)
Compounds containing a pyrimidine ring, whether or not hydrogenated, or piperazine ring in the structure, nesoiFormule :C10H14ON4ClCouleur et forme :Cream PowderMasse moléculaire :241.08561Sodium Picosulfate Related Compound A (4-[(Pyridin-2-yl)(4-hydroxyphenyl)methyl]phenyl sodium sulfate)
CAS :Compounds containing an unfused pyridine ring in the structure, nesoiFormule :C18H14NNaO5SCouleur et forme :White PowderMasse moléculaire :379.04904Diclofenac Potassium
CAS :Aromatic amino-acids and their esters,other than those containing more than one kind of oxygen function for use as drugsFormule :C14H10Cl2KNO2Couleur et forme :White Light Yellow Crystalline PowderMasse moléculaire :334.24Carmustine Related Compound A (1,3-bis(2-chloroethyl)urea)
CAS :Acyclic amides (including acyclic carbamates) and their derivatives and salts thereof, nesoiFormule :C5H10Cl2N2OCouleur et forme :White PowderMasse moléculaire :185.05Linezolid Related Compound C ((S)-5-(aminomethyl)-3-(3-fluoro-4-morpholinophenyl)oxazolidin-2-one)
CAS :Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormule :C14H18FN3O3Couleur et forme :White Off-White Light Yellow PowderMasse moléculaire :295.13322Aminophenylmorpholinone (4-(4-aminophenyl)morpholin-3-one)
CAS :Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormule :C10H12N2O2Couleur et forme :White Off-White SolidMasse moléculaire :192.22Phenobarbital Related Compound A (5-Ethyl-2,6-diimino-5-phenyltetrahydropyrimidin-4(1H)-one)
CAS :Compounds containing a pyrimidine ring (whether or not hydrogenated) or piperazine ring in the structure, nesoiFormule :C12H14N4OCouleur et forme :White SolidMasse moléculaire :230.11676Timolol Related Compound B (3-(tert-Butylamino)-2-(4-morpholino-1,2,5-thiadiazol-3-yloxy)propan-1-ol)
CAS :Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormule :C13H24N4O3SCouleur et forme :White Off-White PowderMasse moléculaire :316.42Leflunomide Related Compound C (N-(3'-Trifluoromethylphenyl)-5-methylisoxazole-4-carboxamide)
CAS :Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormule :C12H9F3N2O2Couleur et forme :Yellow White PowderMasse moléculaire :270.21Dipyridamole Related Compound F (2,2',2'',2'''-({4-[(2-Hydroxyethyl)amino]-8-(piperidin-1-yl)pyrimido[5,4-d]pyrimidine-2,6-diyl}bis(azanetriyl))tetraethanol)
CAS :Compounds containing a pyrimidine ring (whether or not hydrogenated) or piperazine ring in the structure, nesoiFormule :C21H36N8O5Couleur et forme :SolidMasse moléculaire :480.28087Formoterol Related Compound C (N-(2-Hydroxy-5-(1-hydroxy-2-{[1-(4-methoxyphenyl)propan-2-yl]amino}ethyl)phenyl)acetamide fumarate)
CAS :Aromatic cyclic amides (including cyclic carbamates) and their derivatives; salts thereofFormule :(C20H26N2O4)2·C4H4O4Couleur et forme :Off-White Light Brown SolidMasse moléculaire :832.38947Pramipexole Related Compound F ((6S,7R)-2-Amino-6-(propylamino)-4,5,6,7-tetrahydrobenzothiazol-7-ol)
CAS :Compounds containing a benzothiazole ring-system (whether or not hydrogenated), not further fusedFormule :C10H17N3OSCouleur et forme :Off-White SolidMasse moléculaire :227.10923Nepafenac Related Compound A (2-{2-Amino-3-[hydroxy(phenyl)methyl]phenyl}acetamide)
CAS :Aromatic cyclic amides (including cyclic carbamates) and their derivatives; salts thereofFormule :C15H16N2O2Couleur et forme :White SolidMasse moléculaire :256.31Budesonide Related Compound E (16α,17-[butylidenebis(oxy)]-11β,21-dihydroxypregna-1,4,14-triene-3,20-dione)
CAS :Adrenal cortical hormones and their derivatives nesoiFormule :C25H32O6Couleur et forme :PowderMasse moléculaire :428.52Atenolol Related Compound G (2-{4-[2-Hydroxy-3-(isopropylamino)propoxy]phenyl}acetic acid)
CAS :Aromatic amino-alcohol-phenols, aromatic amino-acid-phenols and other aromatic amino compounds with oxygen functionFormule :C14H21NO4Couleur et forme :White SolidMasse moléculaire :267.14706Enalapril Related Compound H (1-{N-[(S)-1-Ethoxycarbonyl-3-cyclohexylpropyl]-L-alanyl}-L-proline, maleate (1:1))
CAS :Heterocyclic compounds (excluding aromatic or modified aromatic) withnitrogen hetero-atom(s) only nesoiFormule :C20H34N2O5·C4H4O4Couleur et forme :White PowderMasse moléculaire :382.5Fludeoxyglucose Related Compound B (2-chloro-2-deoxy-D-glucose)
CAS :Heterocyclic compounds with oxygen hetero-atom(s) only, nesoiFormule :C6H11ClO5Couleur et forme :White Off-White PowderMasse moléculaire :198.6Oxybutynin Related Compound C (4-(ethylmethylamino)but-2-ynyl(+/-)-2-cyclohexyl-2-hydroxy-2-phenylacetate hydrochloride)
Amino-alcohols, other than those containing more than oFormule :C21H30ClNO3Couleur et forme :White PowderMasse moléculaire :379.191423-Amino-2,4,6-triiodobenzoic Acid
CAS :Aromatic amino-acids and their esters, other than those containing more than one kind of oxygen function, not elsewhere specified or includedFormule :C7H4I3NO2Couleur et forme :Light Yellow Amorphous PowderMasse moléculaire :514.82Estriol Related Compound A (Estra-1,3,5(10),9(11)-tetraene-3,16α,17β-triol)
CAS :Estrogens and progestinsFormule :C18H22O3Couleur et forme :Cream Off-White PowderMasse moléculaire :286.15689Oseltamivir Related Compound A ((3S,4R,5S)-Ethyl 4-acetamido-5-amino-2-azido-3-(pentan-3-yloxy)cyclohexanecarboxylate)
CAS :Cyclic amides and their derivatives, nesoiFormule :C16H29N5O4Couleur et forme :White PowderMasse moléculaire :355.44Trandolapril Related Compound D ((S)-ethyl 2-[(3S, 5aS, 9aR, 10aS)-3-methyl-1,4-dioxodecahydropyrazino[1,2-a]indol-2(1H)-yl]-4-phenylbutanoate)
CAS :Aromatic or modified aromatic drugs with nitrogen heterFormule :C24H32N2O4Couleur et forme :White Crystalline PowderMasse moléculaire :412.52Flunixin Related Compound B (2-Methyl-3-(trifluoromethyl)aniline)
CAS :Aromatic monoamines not elsewhere specified or included and their derivatives, salts therofFormule :C8H8F3NCouleur et forme :White Off-White PowderMasse moléculaire :175.06088Hexyl Methanesulfonate
CAS :Hydrocarbon derivatives containing only sulfo groups, their salts andestersFormule :C7H16O3SCouleur et forme :Clear Yellow LiquidMasse moléculaire :180.26Brimonidine Related Compound B (1-(5-Bromoquinoxalin-6-yl)thiourea)
CAS :Heterocyclic compounds with nitrogen hetero-atom(s) only, aromatic or modified aromatic, nesoiFormule :C9H7BrN4SCouleur et forme :White Yellow PowderMasse moléculaire :281.95748Oxazepam Related Compound B (7-Chloro-2-oxo-5-phenyl-2,3-dihydro-1H-benzodiazepin-3-yl acetate)
CAS :Aromatic or modified aromatic heterocyclic compounds withnitrogen heteroFormule :C17H13ClN2O3Couleur et forme :PowderMasse moléculaire :328.06147Spironolactone Related Compound D ((2'R)-7α-(Acetyldisulfanyl)-3',4'-dihydro-5'H-spiro[androst-4-ene-17,2'-furan]-3,5'-dione)
CAS :Adrenal cortical hormones and their derivatives nesoiFormule :C24H32O4S2Couleur et forme :White PowderMasse moléculaire :448.1742Medroxyprogesterone Acetate Related Compound B (17-Hydroxy-6α-methylpregn-4-ene-3,20-dione)
CAS :Estrogens and progestinsFormule :C22H32O3Couleur et forme :White PowderMasse moléculaire :344.49 g/molFebuxostat
CAS :Compounds containing an unfused thiazole ring (whether or not hydrogenated) in the structureFormule :C16H16N2O3SCouleur et forme :White Off-White PowderMasse moléculaire :316.08816Benzhydrol
CAS :Aromatic alcohols and their halogenated, sulfonated, nitrated or nitrosated derivatives not elsewhere specified or includedFormule :C13H12OCouleur et forme :White Off-White PowderMasse moléculaire :184.08882Dofetilide Related Compound A (N-[4-(2-{2-[4-(Methanesulfonamido)phenoxy]ethylamino}ethyl)phenyl]methanesulfonamide)
CAS :Sulfonamides, nesoiFormule :C18H25N3O5S2Couleur et forme :White PowderMasse moléculaire :427.54Voriconazole Related Compound F ({(1RS,4SR)-7,7-Dimethyl-2-oxobicyclo[2.2.1]hept-1-yl}methanesulfonic acid)
CAS :Ketones and quinones, w/not with other oxygen function,and their halogenated,sulfated,nitrated,or nitrosated derivatives, nesoiFormule :C10H16O4SCouleur et forme :White PowderMasse moléculaire :232.3Allopurinol Related Compound A (3-Amino-4-carboxamidopyrazole Hemisulfate)
CAS :Compounds containing an unfused pyrazole ring, whether or not hydrogenated, in the structure, nesoiFormule :C4H6N4OH2O4SCouleur et forme :Off-White Yellow PowderMasse moléculaire :350.31Phenytoin Related Compound A (2,2-Diphenylglycine)
CAS :Aromatic amino-acids and their esters, other than those containing more than one kind of oxygen function, nesoiFormule :C14H13NO2Couleur et forme :White Off-White PowderMasse moléculaire :227.09463Verapamil Related Compound E (3,4-dimethoxybenzaldehyde)
CAS :Aldehyde-ethers, aldehyde-phenols and aldehydes with otFormule :C9H10O3Couleur et forme :PowderMasse moléculaire :166.06299Zaleplon Related Compound C (7-[3-(N-ethylacetamido)phenyl]pyrazolo[1,5-a]pyrimidine-3-carboxamide)
CAS :Compounds containing a pyrimidine ring (whether or not hydrogenated) or piperazine ring in the structure, nesoiFormule :C17H17N5O2Couleur et forme :PowderMasse moléculaire :323.13822Paliperidone Related Compound D (4-(6-Fluorobenzo[d]isoxazol-3-yl)-1-[2-(9-hydroxy-2-methyl-4-oxo-6,7,8,9-tetrahydro-4H-pyrido[1,2-a]pyrimidin-3-yl)ethyl]piperidine 1-oxide)
CAS :Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormule :C23H27FN4O4Couleur et forme :White PowderMasse moléculaire :442.48Azelastine Related Compound B (N'-(1-methylazepan-4-yl)benzohydrazide hydrochloride)
CAS :Heterocyclic compounds with nitrogen hetero-atom(s) only, aromatic or modified aromatic, nesoiFormule :C14H21N3O·HClCouleur et forme :White PowderMasse moléculaire :283.8Buspirone Related Compound A (2-(Piperazin-1-yl)pyrimidine)
CAS :Compounds containing a pyrimidine ring, whether or not hydrogenated, or piperazine ring in the structure, nesoiFormule :C8H12N4Couleur et forme :Clear Light Yellow LiquidMasse moléculaire :164.1062Carglumic Acid Related Compound C ((S)-2-[(S)-4-Carboxy-2-ureidobutanamido]pentanedioic acid)
CAS :Acyclic amides (including acyclic carbamates) and their derivatives and salts thereof, nesoiFormule :C11H17N3O8Couleur et forme :Off-White PowderMasse moléculaire :319.10156Fluorescein Related Compound C (2-(2,4-Dihydroxybenzoyl)benzoic acid)
CAS :Carboxylic acids with additional oxygen function and their anhydrides, halides, peroxides etc, nesoiFormule :C14H10O5Couleur et forme :Off-White Pale Yellow PowderMasse moléculaire :258.05282Ecamsule Related Compound C (terephthalic acid)
CAS :Terephthalic acid and its saltsFormule :C8H6O4Couleur et forme :White Off-White SolidMasse moléculaire :166.13Rivaroxaban Related Compound H ((S)-4,5-Dichloro-N-({2-oxo-3-[4-(3-oxomorpholino)phenyl]oxazolidin-5-yl}methyl)thiophene-2-carboxamide)
CAS :Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormule :C19H17Cl2N3O5SCouleur et forme :Yellow PowderMasse moléculaire :469.0266Clopidogrel Thienopyridinium Chloride (5-(1-(2-chlorophenyl)-2-methoxy-2-oxoethyl)thieno[3,2-c]pyridin-5-ium, chloride)
CAS :Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormule :C16H13ClNO2S·ClCouleur et forme :Off-White SolidMasse moléculaire :318.03555Bendamustine Related Compound B (4-(1-Methyl-5-morpholino-1H-benzimidazol-2-yl)butanoic acid hydrochloride)
Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormule :C16H21N3O3·xHClCouleur et forme :White SolidMasse moléculaire :339.82Anagrelide Related Compound A (ethyl 2-(6-amino-2,3-dichlorobenzylamino)acetate)
CAS :Aromatic amino-acids and their esters, other than those containing more than one kind of oxygen function, nesoiFormule :C11H14Cl2N2O2·HClCouleur et forme :Off-White PowderMasse moléculaire :276.04323Desogestrel Related Compound A (13-Ethyl-11-methylene-18,19-dinor-5α,17α-pregn-3-en-20-yn-17-ol)
CAS :Sterols and inositolsFormule :C22H30OCouleur et forme :White PowderMasse moléculaire :310.22967Exemestane Related Compound A (6-Methyleneandrosta-4-ene-3,17-dione)
CAS :Cyclanic, cyclenic or cycloterpenic ketones without othFormule :C20H26O2Couleur et forme :PowderMasse moléculaire :298.42Cloxacillin Related Compound D (3-(2-Chlorophenyl)-5-methylisoxazole-4-carboxylic acid)
CAS :Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormule :C11H8ClNO3Couleur et forme :PowderMasse moléculaire :237.01927Diltiazem Related Compound A (AS) (trans-diltiazem hydrochloride)
CAS :Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormule :C22H26N2O4SCouleur et forme :PowderMasse moléculaire :450.98Tinidazole Related Compound B (1-(2-ethyl-sulfonylethyl)-2-methyl-4-nitroimidazole)
CAS :Compounds containing an unfused imidazole ring (whether or not hydrogenated) in the structure nesoiFormule :C8H13N3O4SCouleur et forme :Off-White Cream PowderMasse moléculaire :247.28Guaiacol
CAS :Ether-phenols, ether-alcohol-phenols and their halogenated, sulfonated, nitrated or nitrosated derivativesFormule :C7H8O2Couleur et forme :Pale Yellow LiquidMasse moléculaire :124.05243Diphenhydramine Related Compound B (3-(benzhydryloxy)propane-1,2-diol)
CAS :Carboxylic acids with additional oxygen function and their anhydrides, halides, peroxides etc not elsewhere specified or includedFormule :C16H18O3Couleur et forme :SolidMasse moléculaire :258.12559Imiquimod Related Compound D (1-Propyl-1H-imidazo[4,5-c]quinolin-4-amine)
CAS :Heterocyclic compounds with nitrogen hetero-atom(s) only, aromatic or modified aromatic, nesoiFormule :C13H14N4Couleur et forme :Off-White PowderMasse moléculaire :226.12185Roflumilast Related Compound E (N-(3-Bromo-5-chloropyridin-4-yl)-3-(cyclopropylmethoxy)-4-(difluoromethoxy)benzamide)
CAS :Compounds containing an unfused pyridine ring in the structure, nesoiFormule :C17H14BrClF2N2O3Couleur et forme :White Beige PowderMasse moléculaire :445.98444Guanylmelamine Dinitrate (1-(4,6-diamino-1,3,5-triazin-2-yl)guanidine, nitrate)
CAS :Compounds (excluding melamine) containing an unfused triazine ring (whether or not hydrogenated) in the structureFormule :C4H8N8·2HNO3Couleur et forme :Off-White SolidMasse moléculaire :168.08719Miconazole Related Compound I (1-{2-[(2-Chlorobenzyl)oxy]-2-(2,4-dichlorophenyl)ethyl}-1H-imidazole mononitrate)
CAS :Compounds containing an unfused imidazole ring, whether or not hydrogenated, in the structure, nesoiFormule :C18H15Cl3N2O·HNO3Couleur et forme :White Off-White PowderMasse moléculaire :443.02064Rivaroxaban N-acyl glycolic acid ((S)-2-(2-(5-chloro-N-(4-(5-((5-chlorothiophene-2-carboxamido)methyl)-2-oxooxazolidin-3-yl)phenyl)thiophene-2-carboxamido)ethoxy)acetic acid)
CAS :Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormule :C24H21Cl2N3O7S2Couleur et forme :Off-White SolidMasse moléculaire :597.0198Triclocarban Related Compound A (1,3-Bis(4-chlorophenyl)urea)
CAS :Ureines and their derivatives; salts thereofFormule :C13H10Cl2N2OCouleur et forme :White Off-White PowderMasse moléculaire :281.14Valproic Acid Related Compound A (2-allylpent-4-enoic acid)
CAS :Unsaturated acyclic monocarboxylic acids, their anhydrides, halides, peroxides, peroxyacids and their derivatives, nesoiFormule :C8H12O2Couleur et forme :Clear LiquidMasse moléculaire :140.08373Aprepitant Related Compound B (3-[[(2S,3R)-2-[(S)-1-[3,5-Bis(trifluoromethyl)phenyl]ethoxy]-3-(4-fluorophenyl)morpholino]methyl]-1H-1,2,4-triazol-5(4H)-one)
CAS :Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormule :C23H21F7N4O3Couleur et forme :White Off-White Crystalline PowderMasse moléculaire :534.15019Oxaliplatin Related Compound F ([SP-4-2-(1R-trans)]-(1,2-cyclohexanediamine-N,N') diiodidoplatinum(II))
CAS :Inorganic or organic compounds of precious metals, whetFormule :C6H14N2I2PtCouleur et forme :PowderMasse moléculaire :563.09Perphenazine Related Compound B (2-{4-[3-(10H-phenothiazin-10-yl)propyl]piperazin-1-yl}ethanol)
CAS :Compounds (excluding drugs) containing a phenothiazine ring-system (whether or not hydrogenated), not further fusedFormule :C21H27N3OSCouleur et forme :Off-White PowderMasse moléculaire :369.18748Levocabastine Related Compound A (1-[cis-4-cyano-4-(4-fluorophenyl)cyclohexyl]-4-phenylpiperidine-4-carboxylic acid hydrochloride)
CAS :Compounds containing an unfused pyridine ring in the structure, nesoiFormule :C25H27FN2O2·HClCouleur et forme :White PowderMasse moléculaire :406.20566Lovastatin Epimer Mixture (Epilovastatin and Lovastatin 1:1 Mixture)
Lactones nesoiFormule :C24H36O5Couleur et forme :PowderMasse moléculaire :404.25627Methoxsalen Related Compound B (4,9-Dimethoxy-7H-furo[3,2-g]chromen-7-one)
CAS :Aromatic lactones used as drugsFormule :C13H10O5Couleur et forme :PowderMasse moléculaire :246.05282Cyproheptadine Related Compound A (5H-dibenzo[a,d]cycloheptene)
CAS :Cyclic hydrocarbons not elsewhere specified or includedFormule :C15H12Couleur et forme :Pale Yellow PowderMasse moléculaire :192.0939Dobutamine Related Compound C (N-(3,4-Dimethoxyphenethyl)-4-(4-methoxyphenyl)butan-2-amine hydrochloride)
CAS :Amino-naphthols and other amino-phenols, their ethers and esters, other than those cont more than one kind of oxygen function; salts thereof nesoiFormule :C21H29NO3·HClCouleur et forme :White PowderMasse moléculaire :379.19142Flavoxate Related Compound A (3-Methyl-4-oxo-2-phenyl-4H-chromene-8-carboxylic acid)
CAS :Aromatic heterocyclic compounds with oxygen hetero-atom(s) only, nesoiFormule :C17H12O4Couleur et forme :White Off-White PowderMasse moléculaire :280.28Amlodipine Related Compound B (3-Ethyl 5-methyl 4-(2-chlorophenyl)-6-methyl-2-({2-[2-(methylcarbamoyl)benzamido]ethoxy}methyl)-1,4-dihydropyridine-3,5-dicarboxylate)
CAS :Compounds containing an unfused pyridine ring in the structure, nesoiFormule :C29H32ClN3O7Couleur et forme :White PowderMasse moléculaire :569.19288Pyrazinamide Related Compound B (Pyrazinecarbonitrile)
CAS :Aromatic or modified aromatic heterocyclic compounds withnitrogen hetero-atom(s) only nesoiFormule :C5H3N3Couleur et forme :White PowderMasse moléculaire :105.0327Fosinopril Related Compound E ((4S)-4-Phenyl-1-[(R)-[(S)-1-hydroxy-2-methylpropoxy](4-phenylbutyl)phosphinyl]acetyl-L-proline propionate (ester), sodium salt)
CAS :Heterocyclic compounds with nitrogen hetero-atom(s) only, aromatic or modified aromatic, nesoiFormule :C30H39NNaO7PCouleur et forme :White PowderMasse moléculaire :579.23618Iodixanol Related Compound C (5-[Acetyl[3-[[3,5-bis[[(2,3-dihydroxypropyl)amino]carbonyl]-2,4,6-triiodophenyl]amino]-2-hydroxypropyl]amino]-N,N'-bis-(2,3-dihydroxypropyl)-2,4,6-triiodo-1,3-benzenedicarboxamide)
CAS :Aromatic cyclic amides (including cyclic carbamates) and their derivatives; salts thereofFormule :C33H42I6N6O14Couleur et forme :White Off-White PowderMasse moléculaire :1508.15Albuterol Related Compound F (4-[2-(tert-Butylamino)-1-ethoxyethyl]-2-(hydroxymethyl)phenol)
CAS :Aromatic amino-alcohol-phenols, aromatic amino-acid-pheFormule :C15H25NO3Couleur et forme :White SolidMasse moléculaire :267.37Milnacipran Related Compound A (2-(Aminomethyl)-1-phenylcyclopropane-1-carboxylic acid hydrochloride)
CAS :Aromatic amino-acids and their esters,other than thoseFormule :C11H13NO2HClCouleur et forme :Off-White White SolidMasse moléculaire :227.69Perphenazine Sulfoxide
CAS :Compounds (excluding drugs) containing a phenothiazine ring-system (whether or not hydrogenated), not further fusedFormule :C21H26ClN3O2SCouleur et forme :White Crystalline PowderMasse moléculaire :419.14343Praziquantel Related Compound B (2-(cyclohexylcarbonyl)-2,3,6,7-tetrahydro-4H-pyrazino [2,1-a]isoquinolin-4-one)
CAS :Compounds containing a pyrimidine ring (whether or notFormule :C19H22N2O2Couleur et forme :Pale Yellow PowderMasse moléculaire :310.16813Chloro N-methylthiophene Carboxamide (5-chloro-N-methylthiophene-2-carboxamide)
CAS :Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormule :C6H6ClNOSCouleur et forme :White Off-White SolidMasse moléculaire :174.98586Dapagliflozin Related Compound A ((2S,3R,4R,5S,6R)-2-[4-Bromo-3-(4-ethoxybenzyl)phenyl]-6-(hydroxymethyl)tetrahydro-2H-pyran-3,4,5-triol)
CAS :Aromatic heterocyclic compounds with oxygen hetero-atom(s) only, nesoiFormule :C21H25BrO6Couleur et forme :White SolidMasse moléculaire :452.08345Fluoroquinolonic Acid
CAS :Compounds (excluding drugs and pesticides) containing aFormule :C13H9ClFNO3Couleur et forme :Beige PowderMasse moléculaire :281.67Bosentan Related Compound B (4-(tert-butyl)-N-[6-hydroxy-5-(2-methoxyphenoxy)-(2,2'-bipyrimidin)-4-yl]benzenesulfonamide)
CAS :Sulfonamides, nesoiFormule :C25H25N5O5SCouleur et forme :White PowderMasse moléculaire :507.15764Acetylcysteine Related Compound D (N,S-Diacetyl-L-Cysteine)
CAS :Other organo-sulfur acid compoundsFormule :C7H11NO4SCouleur et forme :White SolidMasse moléculaire :205.04088Granisetron Related Compound E ((1R,3r,5S)-9-methyl-9-azabicyclo[3.3.1]nonan-3-amine acetate)
CAS :Compounds containing an unfused pyridine ring in the structure, nesoiFormule :C9H18N2·C2H4O2Couleur et forme :Off-White PowderMasse moléculaire :214.31Sevoflurane Related Compound B (1,1,1,3,3,3-hexafluoro-2-methoxy-propane)
CAS :Ethers of monohydric alcohols, nesoiFormule :C4H4F6OCouleur et forme :Clear Colorless LiquidMasse moléculaire :182.08Levalbuterol Related Compound F ((R)-1-[4-(Benzyloxy)-3-(hydroxymethyl)phenyl]-2-(tert-butylamino)ethan-1-ol)
CAS :Aromatic amino-alcohol-phenols, aromatic amino-acid-phenols and other aromatic amino compounds with oxygen functionFormule :C20H27N03Couleur et forme :White Off-White SolidMasse moléculaire :309.2205Cefuroxime Axetil E-isomers ((1RS,6R,7R)-1-Acetoxyethyl 3-[(carbamoyloxy)methyl]-7-[(E)-2-(furan-2-yl)-2-(methoxyimino)acetamido]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate)
CAS :Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormule :C20H22N4O10SCouleur et forme :Pale Yellow PowderMasse moléculaire :510.10566Indomethacin Related Compound A (2-(5-methoxy-2-methyl-1H-indol-3-yl)acetic acid)
CAS :Aromatic or modified aromatic drugs with nitrogen heteroFormule :C12H13NO3Couleur et forme :Light Yellow Crystalline PowderMasse moléculaire :219.08954Celecoxib Related Compound D ((E)-4-{2-[1-(p-Tolyl)ethylidene]hydrazineyl}benzenesulfonamide)
CAS :Sulfonamides, nesoiFormule :C15H17N3O2SCouleur et forme :Pale Yellow Off-White SolidMasse moléculaire :303.10415Entacapone Related Compound A ((Z)-2-cyano-3-(3,4-dihydroxy-5-nitrophenyl)-N,N-diethylacrylamide)
CAS :Nitrile function compounds, nesoiFormule :C14H15N3O5Couleur et forme :Dark Orange PowderMasse moléculaire :305.29Imiquimod Related Compound C (4-Chloro-1-isobutyl-1H-imidazo[4,5-c]quinoline)
CAS :Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormule :C14H14ClN3Couleur et forme :White Crystalline PowderMasse moléculaire :259.08763Voriconazole Related Compound C (1-(2,4-Difluorophenyl)-2-(1H-1,2,4-triazol-1-yl)ethanone)
Aromatic or modified aromatic heterocyclic compounds withnitrogen hetero-atom(s) only nesoiFormule :C10H7F2N3OCouleur et forme :Pale Yellow SolidMasse moléculaire :223.18Cephalexin Related Compound D (3-Hydroxy-4-methylthiophen-2(5H)-one)
CAS :Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormule :C5H6O2SCouleur et forme :SolidMasse moléculaire :130.00885Palonosetron Related Compound C ((S)-2-[(3R)-Quinuclidin-3-yl]-2,3,3a,4,5,6-hexahydro-1H-benzo[de]isoquinolin-1-one hydrochloride)
CAS :Lactams, nesoiFormule :C19H24N2O·HClCouleur et forme :Off-White White Pale Yellow SolidMasse moléculaire :332.87Nicotine Related Compound B (3-(1-methyl-1H-pyrrol-2-yl)pyridine)
CAS :Other alkaloids,natural or reproduced by synthesis, and their salts, ethers,esters&other derivatives, nesoiFormule :C10H10N2Couleur et forme :Colorless Light Yellow Oily LiquidMasse moléculaire :158.0844Zolmitriptan Related Compound B ((S)-2-Amino-3-{3-[2-(dimethylamino)ethyl]-1H-indol-5-yl}propan-1-ol)
CAS :Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormule :C15H23N3OCouleur et forme :White SolidMasse moléculaire :261.18411Methoxymethylguanine
CAS :Compounds containing a pyrimidine ring (whether or not hydrogenated) or piperazine ring in the structure, nesoiFormule :C7H9N5O2Couleur et forme :Light Yellow PowderMasse moléculaire :195.18Rivaroxaban Ethyl Carbamate (ethyl (4-(3-oxomorpholino)phenyl)carbamate)
CAS :Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormule :C13H16N2O4Couleur et forme :White Off-White SolidMasse moléculaire :264.11101Estradiol Related Compound B (1,3,5(10),6-estratetraen-3,17β-diol)
CAS :Estrogens and progestinsFormule :C18H22O2Couleur et forme :White Yellow Crystalline PowderMasse moléculaire :270.16198Febuxostat Related Compound E (2-(3-Cyano-4-propoxyphenyl)-4-methylthiazole-5-carboxylic acid)
CAS :Compounds containing an unfused thiazole ring (whether or not hydrogenated) in the structureFormule :C15H14N2O3SCouleur et forme :White Fine PowderMasse moléculaire :302.07251Glimepiride Related Compound C ((Methyl ({4-[2-(3-ethyl-4-methyl-2-oxo-2,5-dihydro-1H-pyrrole-1-carboxamido)ethyl]phenyl}sulfonyl)carbamate)
CAS :Sulfonamides, nesoiFormule :C18H23N3O6SCouleur et forme :White Crystalline PowderMasse moléculaire :409.13076Dipyridamole Related Compound A (2,2'-{[4,6,8-Tri(piperidin-1-yl)pyrimido[5,4-d]pyrimidin-2-yl]azanediyl}diethanol)
CAS :Compounds containing a pyrimidine ring (whether or not hydrogenated) or piperazine ring in the structure, nesoiFormule :C25H40N8O2Couleur et forme :Yellow PowderMasse moléculaire :484.32742Losartan Related Compound B (2-Butyl-4-chloro-(1-{[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl}-1H-imidazol-5-yl)methyl acetate)
CAS :Compounds containing an unfused imidazole ring (whether or not hydrogenated) in the structure nesoiFormule :C24H25ClN6O2Couleur et forme :PowderMasse moléculaire :464.17275Cidofovir Enantiomer (1-[(R)-3-Hydroxy-2-(phosphonomethoxy)propyl]cytosine)
CAS :Compounds containing a pyrimidine ring, whether or not hydrogenated, or piperazine ring in the structure, nesoiFormule :C8H14N3O6PCouleur et forme :White Off-White PowderMasse moléculaire :279.06202Granisetron Related Compound D (1-Methyl-1H-indazole-3-carboxylic acid)
CAS :Aromatic or modified aromatic heterocyclic compounds withnitrogen hetero-atom(s) only nesoiFormule :C9H8N2O2Couleur et forme :Pale Yellow PowderMasse moléculaire :176.18Azelastine Related Compound F (4-[4-(4-Chlorobenzyl)-1-oxophthalazin-2(1H)-yl]-1-methylazepane 1-oxide)
CAS :Heterocyclic compounds with nitrogen hetero-atom(s) only, aromatic or modified aromatic, nesoiFormule :C22H24ClN3O2Couleur et forme :White SolidMasse moléculaire :397.1557Rivastigmine Related Compound B ((R,S)-3-[1-(Dimethylamino)ethyl]phenyl dimethylcarbamate)
CAS :Aromatic cyclic amides (including cyclic carbamates) anFormule :C13H20N2O2Couleur et forme :Yellow LiquidMasse moléculaire :236.15248Buspirone Related Compound L (8-(4-Chlorobutyl)-8-azaspiro[4.5]decane-7,9-dione)
CAS :Imides and their derivatives (excluding sacharin), salt thereofFormule :C13H20ClNO2Couleur et forme :Colorless Clear Light Yellow LiquidMasse moléculaire :257.11826Sotalol Related Compound A (N-[4-[[(1-Methylethyl)amino]acetyl]phenyl]methanesulfonamide monohydrochloride)
Sulfonamides, excluding drugsFormule :C12H18N2O3S·HClCouleur et forme :PowderMasse moléculaire :306.81Risperidone Related Compounds Mixture
Diagnostic or lab reagents on a backing, prepared diagnostic or lab reagents whether or not on a backing, whether or not in the form of kits, nesoiCouleur et forme :White Off-White PowderMiconazole Related Compound C (2-[(2,4-Dichlorobenzyl)oxy]-2-(2,4-dichlorophenyl)ethan-1-amine hydrochloride)
CAS :Amino-alcohols, other than those containing more than one kind of oxygen function, their ethers and esters, salts thereof, nesoiFormule :C15H13Cl4NO·HClCouleur et forme :White Off-White SolidMasse moléculaire :401.53p-Ranolazine (N-(2,6-Dimethylphenyl)-2-{4-[2-hydroxy-3-(4-methoxyphenoxy)propyl]piperazin-1-yl}acetamide)
CAS :Drugs containing a pyrimidine ring (whether or not hydrogenated) or piperazine ring in the structureFormule :C24H33N3O4Couleur et forme :White PowderMasse moléculaire :427.55Dextroamphetamine Related Compound A (1-Phenyl-2-propanol)
CAS :Aromatic alcohols and their halogenated, sulfonated, nitrated or nitrosated derivatives, nesoiFormule :C9H12OCouleur et forme :Colorless LiquidMasse moléculaire :136.19Prasugrel Related Compound D (5-[2-Cyclopropyl-1-(2-fluorophenyl)-2-oxoethyl]-5,6,7,7a-tetrahydrothieno[3,2-c]pyridin-2(4H)-one)
CAS :Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormule :C18H18FNO2SCouleur et forme :Off-White PowderMasse moléculaire :331.10423Ecamsule Related Compound F (4-((E)-((1SR,4SR)-7,7-dimethyl-3-oxo-4-(sulfomethyl)bicyclo[2.2.1]heptan-2-ylidene)methyl)benzoic acid)
CAS :Carboxylic acids with aldehyde or ketone function but without other oxygen function, their anhydrides, halides, peroxides, peroxyacids andtheir derivFormule :C18H20O6SCouleur et forme :White PowderMasse moléculaire :364.09806Efavirenz Related Compound C (6-chloro-2-cyclopropyl-4-(trifluoromethyl)quinoline)
CAS :Compounds (excluding drugs and pesticides) containing a quinoline or isoquinoline ring-system (whether or not hydrogenated) not further fused, nesoiFormule :C13H9ClF3NCouleur et forme :Off-White PowderMasse moléculaire :271.03756Memantine Related Compound G (3-Methyladamantan-1-amine hydrochloride)
CAS :Cyclanic, cyclenic or cycloterpenic mono- or polyamines, and their derivatives; salts thereofFormule :C11H19N·HClCouleur et forme :White PowderMasse moléculaire :201.12843Amoxicillin Related Compounds D and E Mixture
Diagnostic or lab reagents on a backing, prepared diagnostic or lab reagents whether or not on a backing, whether or not in the form of kits, nesoiCouleur et forme :White PowderProguanil Related Compound A (1-cyano-3-isopropylguanidine)
CAS :Nitrile function compounds, not elsewhere specified orFormule :C5H10N4Couleur et forme :White Crystalline PowderMasse moléculaire :126.09055Cyclobenzaprine Related Compound B (3-(5H-dibenzo[a,d]cyclohepten-5-ylidene)-N-methyl-1-propanamine, hydrochloride)
CAS :Aromatic monoamines and their derivatives, salts thereof, nesoiFormule :C19H19N·HClCouleur et forme :White PowderMasse moléculaire :297.82Carbinoxamine Related Compound A ((4-Chlorophenyl)(pyridin-2-yl)methanone)
CAS :Compounds containing an unfused pyridine ring in the structure, nesoiFormule :C12H8ClNOCouleur et forme :White Yellow Crystalline PowderMasse moléculaire :217.02944Dorzolamide Related Compound D ((4S,6S)-4-Amino-6-methyl-5,6-dihydro-4H-thieno[2,3-b]thiopyran-2-sulfonamide 7,7-dioxide hydrochloride)
CAS :Sulfonamides, nesoiFormule :C8H12N2O4S3·HClCouleur et forme :White Off-White PowderMasse moléculaire :295.99592Metoclopramide Related Compound B (Methyl 4-acetamido-5-chloro-2-methoxybenzoate)
CAS :Aromatic cyclic amides (including cyclic carbamates) and their derivatives; salts thereofFormule :C11H12ClNO4Couleur et forme :White Off-White PowderMasse moléculaire :257.04549Ciprofloxacin Related Compound A (7-Chloro-1-cyclopropyl-4-oxo-6-(piperazin-1-yl)-1,4-dihydroquinoline-3-carboxylic acid hydrochloride salt)
Compounds containing a pyrimidine ring (whether or notFormule :C17H18N3O3Cl·HClCouleur et forme :Pale Yellow PowderMasse moléculaire :384.26Rosiglitazone Related Compound A ((5Z)-5-{[4-({2-[methyl(2-pyridinyl)amino]ethyl}oxy)phenyl]methylidene}-1,3-thiazolidine-2,4-dione)
CAS :Compounds containing an unfused thiazole ring (whetherFormule :C18H17N3O3SCouleur et forme :Yellow SolidMasse moléculaire :355.09906Azaerythromycin A (9-Deoxo-9a-aza-9a-homoerythromycin A)
CAS :Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormule :C37H70N2O12Couleur et forme :White PowderMasse moléculaire :734.49288Cilostazol Related Compound A (6-hydroxy-3,4-dihydro-1H-quinolin-2-one)
CAS :Lactams not elsewhere specified or includedFormule :C9H9NO2Couleur et forme :Yellow White PowderMasse moléculaire :163.17Atenolol Related Compound B (2-[4-(2,3-Dihydroxypropoxy)phenyl]acetamide)
CAS :Aromatic cyclic amides (including cyclic carbamates) and their derivatives; salts thereofFormule :C11H15NO4Couleur et forme :White PowderMasse moléculaire :225.10011Praziquantel Related Compound C (2-(N-formylhexahydrohippuroyl)-1,2,3,4-tetrahydroisoquinolin-1-one)
CAS :Lactams not elsewhere specified or includedFormule :C19H22N2O4Couleur et forme :White Crystalline PowderMasse moléculaire :342.15796Efavirenz Related Compound A ((S)-2-(2-amino-5-chlorophenyl)-4-cyclopropyl-1,1,1-trifluorobut-3-yn-2-ol)
CAS :Amino-alcohols, other than those containing more than one kind of oxygen function, their ethers and esters, salts therof, nesoiFormule :C13H11NOF3ClCouleur et forme :White PowderMasse moléculaire :289.04813Apixaban Related Compound H (Ethyl 6-[4-(5-chloropentanamido)phenyl]-1-(4-methoxyphenyl)-7-oxo-4,5,6,7-tetrahydro-1H-pyrazolo[3,4-c]pyridine-3-carboxylate)
CAS :Lactams, nesoiFormule :C27H29ClN4O5Couleur et forme :Off-White PowderMasse moléculaire :525Atomoxetine Related Compound A (3-(Methylamino)-1-phenylpropan-1-ol)
CAS :Amino-alcohols, other than those containing more than one kind of oxygen function, their ethers and esters, salts therof, nesoiFormule :C10H15NOCouleur et forme :White Off-White Light Yellow PowderMasse moléculaire :165.11536Saquinavir Related Compound A (N-tert-butyl-decahydro-2-[2(R)-hydroxy-4-phenyl-3(S)-[[N-(2-quinolylcarbonyl)-D-asparaginyl]amino]butyl]-(4aS,8aS)-isoquinoline-3(S)-carboxamide)
CAS :Compounds (excluding drugs and pesticides) containing a quinoline or isoquinoline ring-system (whether or not hydrogenated) not further fused, nesoiFormule :C38H50N6O5Couleur et forme :White Crystalline PowderMasse moléculaire :670.38427Clopidogrel Related Compound C (methyl (-)-(R)-(o-chlorophenyl)-6,7-dihydrothieno[3,2-c]pyridine-5(4H)-acetate, hydrogen sulfate)
CAS :Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormule :C16H16ClNO2S·H2SO4Couleur et forme :White PowderMasse moléculaire :321.05903Progesterone Related Compound H (Pregna-4,6-diene-3,20-dione)
CAS :Estrogens and progestinsFormule :C21H30O2Couleur et forme :Pale Yellow Off-White PowderMasse moléculaire :314.22458Methylene Simvastatin ((1S,3R,7S,8S,8aR)-8-{2-[(2R,4R)-4-hydroxy-6-oxotetrahydro-2H-pyran-2-yl]ethyl}-3,7-dimethyl-1,2,3,7,8,8a-hexahydronaphthalen-1-yl 2,2-dimethylbut-3-enoate)
CAS :Lactones nesoiFormule :C25H36O5Couleur et forme :White PowderMasse moléculaire :416.55Warfarin Related Compound A (3-(o-hydroxyphenyl)-5-phenyl-2-cyclohexen-1-one)
CAS :Ketone-phenols and ketones with other oxygen functionFormule :C18H16O2Couleur et forme :White Pale Yellow Crystals NeedlesMasse moléculaire :264.115032-Mononitroglycerin
CAS :Esters of other inorganic acids of nonmetals & their salts, their halogenated/sulfonated/nitrated/nitrosated derivs, except of hydrogen halides, nesoiFormule :C3H7NO5Couleur et forme :Clear Colorless LiquidMasse moléculaire :137.03242Methylprednisolone Hemisuccinate Related Compound D (11β,17-Dihydroxy-6α-methyl-3,20-dioxopregna-4-en-21-yl hydrogen succinate)
CAS :Adrenal cortical hormones and their derivatives nesoiFormule :C26H36O8Couleur et forme :White Off-White SolidMasse moléculaire :476.24102Amoxicillin Related Compound C ((4S)-2-[5-(4-hydroxyphenyl)-3,6-dioxopiperazin-2-yl]-5,5-dimethylthiazolidine-4-carboxylic acid)
CAS :Compounds containing an unfused thiazole ring (whether or not hydrogenated) in the structureFormule :C16H19N3O5SCouleur et forme :White PowderMasse moléculaire :365.41Nebivolol Related Compound C ((RS)-6-Fluoro-2-[(RS)-oxiran-2-yl]chroman)
CAS :Aromatic pesticides with oxygen heteroFormule :C11H11FO2Couleur et forme :Liquid Low-Melting SolidMasse moléculaire :194.2Metformin Related Compound C (N,N-Dimethyl-[1,3,5]triazine-2,4,6-triamine)
CAS :Compounds (excluding melamine) containing an unfused triazine ring (whether or not hydrogenated) in the structureFormule :C5H10N6Couleur et forme :White Off-White PowderMasse moléculaire :154.09669Norgestimate Related Compound A (Levonorgestrel acetate)
CAS :Estrogens and progestinsFormule :C23H30O3Couleur et forme :White Off-White PowderMasse moléculaire :354.21949Benzyl Chloride ((Chloromethyl)benzene)
CAS :Halogenated derivatives of aromatic hydrocarbons, nesoiFormule :C7H7ClCouleur et forme :Clear Colorless LiquidMasse moléculaire :126.58Nebivolol Related Compound B (See USP Certificate for full Chemical Name)
Aromatic pesticides with oxygen heteroFormule :C22H25F2NO4·HClCouleur et forme :PowderMasse moléculaire :441.15184Clonazepam Related Compound C (2-bromo-2'-(2-chlorobenzoyl)-4'-nitroacetanilide)
CAS :Aromatic cyclic amides (including cyclic carbamates) and their derivatives; salts thereofFormule :C15H10BrClN2O4Couleur et forme :White PowderMasse moléculaire :395.95125Roflumilast Related Compound C (3,5-Dichloropyridin-4-amine)
CAS :Compounds containing an unfused pyridine ring in the structure, nesoiFormule :C5H4Cl2N2Couleur et forme :White Yellow PowderMasse moléculaire :161.97515Nevirapine Related Compound B (5,11-Dihydro-4-methyl-6H-dipyrido[3,2-b:2',3'-e][1,4]diazepin-6-one)
CAS :Aromatic or modified aromatic drugs with nitrogen hetero-atom(s) only, not elsewhere specified or includedFormule :C12H10N4OCouleur et forme :Yellow Green PowderMasse moléculaire :226.08546
![Voriconazole Related Compound F ({(1RS,4SR)-7,7-Dimethyl-2-oxobicyclo[2.2.1]hept-1-yl}methanesulfo…](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2F45%2Fthumb-webp%2F1718063.webp&w=3840&q=75)
![Perphenazine Related Compound B (2-{4-[3-(10H-phenothiazin-10-yl)propyl]piperazin-1-yl}ethanol)](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2F45%2Fthumb-webp%2F1511021.webp&w=3840&q=75)
![Levalbuterol Related Compound F ((R)-1-[4-(Benzyloxy)-3-(hydroxymethyl)phenyl]-2-(tert-butylamino)…](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2F45%2Fthumb-webp%2F1358842.webp&w=3840&q=75)
![Palonosetron Related Compound C ((S)-2-[(3R)-Quinuclidin-3-yl]-2,3,3a,4,5,6-hexahydro-1H-benzo[de]…](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2F45%2Fthumb-webp%2F1492244.webp&w=3840&q=75)
![Rivastigmine Related Compound B ((R,S)-3-[1-(Dimethylamino)ethyl]phenyl dimethylcarbamate)](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2F45%2Fthumb-webp%2F1604870.webp&w=3840&q=75)
![Buspirone Related Compound L (8-(4-Chlorobutyl)-8-azaspiro[4.5]decane-7,9-dione)](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2F45%2Fthumb-webp%2F1078824.webp&w=3840&q=75)
![Cyclobenzaprine Related Compound B (3-(5H-dibenzo[a,d]cyclohepten-5-ylidene)-N-methyl-1-propanamin…](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2F45%2Fthumb-webp%2F1154525.webp&w=3840&q=75)
![Dorzolamide Related Compound D ((4S,6S)-4-Amino-6-methyl-5,6-dihydro-4H-thieno[2,3-b]thiopyran-2-s…](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2F45%2Fthumb-webp%2F1225306.webp&w=3840&q=75)
